Tag results:

muscle cells

Adiponectin Receptor Agonist Ameliorates Cardiac Lipotoxicity via Enhancing Ceramide Metabolism in Type 2 Diabetic Mice

[Cell Death & Disease] Phenotypic and metabolic profiles with associated cellular signaling pathways involved in lipid metabolism were investigated in the mice heart and human cardiomyocytes to establish treatment effect of adiponectin's agonists.

Irisin Protects against Vascular Calcification by Activating Autophagy and Inhibiting NLRP3-Mediated Vascular Smooth Muscle Cell Pyroptosis in Chronic Kidney Disease

[Cell Death & Disease] Irisin effectively inhibited β-GP-induced calcium deposition in VSMCs in vitro and in mice aortic rings ex vivo. Overexpression of Nlrp3 attenuated the suppressive effect of Irisin on VSMC calcification.

IL-6 Promotes Chemoresistance via Upregulating CD36 Mediated Fatty Acids Uptake in Acute Myeloid Leukemia

[Experimental Cell Research] The authors found that lipid transport-associated genes were upregulated in the high interleukin-6 (IL-6) receptor expression group. IL-6 promoted fatty acid uptake in both AML cell lines and primary AML cells.

Bone Marrow Mesenchymal Stem Cell-Derived Exosomal microRNA-381-3p Alleviates Vascular Calcification in Chronic Kidney Disease by Targeting NFAT5

[Cell Death & Disease] The authors investigated the mechanism of bone marrow MSC-derived exosome using high phosphate stimulated human aortic smooth muscle cells and 5/6 subtotal nephrectomy rat models.

miRNA/mRNA Co-Profiling Identifies the miR-200 Family as a Central Regulator of SMC Quiescence

[iScience] Scientists unraveled the substantial contribution of miRNAs in regulating the smooth muscle cell (SMC) transcriptome and identified the miR-200 cluster as a pro-quiescence mechanism and a potential inhibitor of vascular restenosis.

Doxorubicin Induced Immune Abnormalities and Inflammatory Responses via HMGB1, HIF1-α and VEGF Pathway in Progressive of Cardiovascular Damage

[Annals of Medicine] The authors comprehensively review the role of high-mobility group box 1 (HMGB1), hypoxia-inducible factor-1α (HIF-1α), and VEGF in doxorubicin-induced cardiovascular disease and its molecular mechanisms.

Popular